A physical therapist is working with a female patient with T8 AIS A SCI. The patient asks about birth control options. Which of the following is an important consideration regarding oral contraceptives for women with SCI?

A physical therapist is working with a female patient with T8 AIS A SCI. The patient asks about birth control options. Which of the following is an important consideration regarding oral contraceptives for women with SCI?

• A. Oral contraceptives are the preferred method for all women with SCI
• B. Women with SCI are at increased risk for deep vein thrombosis, and oral contraceptives may further increase this risk
• C. Oral contraceptives improve bone density in women with SCI
• D. There are no contraindications to oral contraceptive use in women with SCI

Answer: (B)

The key idea here is venous thromboembolism risk in people with spinal cord injury and how estrogen-containing contraception affects that risk. A spinal cord injury, especially with immobility, increases venous stasis and the chance of DVT. Estrogen in oral contraceptives further promotes a procoagulant state, increasing the likelihood of clot formation. So, using combined estrogen-progestin oral contraceptives in someone with SCI can meaningfully raise the risk of DVT, making it a less safe choice for birth control in this population. Safer options include non-estrogen methods (like progestin-only pills, implants, or certain intrauterine devices) after medical consultation. It’s not correct to say there are no contraindications or that all women with SCI should use OCPs, and there isn’t evidence that oral contraceptives improve bone density in SCI—bone loss here is primarily due to disuse, not hormonal effects.

The key idea here is venous thromboembolism risk in people with spinal cord injury and how estrogen-containing contraception affects that risk. A spinal cord injury, especially with immobility, increases venous stasis and the chance of DVT. Estrogen in oral contraceptives further promotes a procoagulant state, increasing the likelihood of clot formation. So, using combined estrogen-progestin oral contraceptives in someone with SCI can meaningfully raise the risk of DVT, making it a less safe choice for birth control in this population. Safer options include non-estrogen methods (like progestin-only pills, implants, or certain intrauterine devices) after medical consultation. It’s not correct to say there are no contraindications or that all women with SCI should use OCPs, and there isn’t evidence that oral contraceptives improve bone density in SCI—bone loss here is primarily due to disuse, not hormonal effects.